RESEARCH Vol. 13 Press Ltd. 1978.
THROMBOSIS @Pergamon
CALCIUM
BINDING
TO HUMAN
OF
G.G.
pp. 345-350 Printed in Great Britain 00~~-~8~8/~8/0~01-03~j
TWO
CALCIUM
LtNDSEY,
G.
Department University
of
L.R.
Medical Cape
South
Accepted
PURVES
Pathology,
Town 7925,
Republic
9.6.1978.
and
Chemical
Cape
Observatory
(Received
FIBRINOGEN - LOC,4LIZATlON SPECIFIC SITES
BROWN
of
of
$02.00/o
School,
Town,
Africa.
by
Editor
R.F.
Doolittle)
ABSTRACT In this
report
calcium Dd
we
specific
omains.
sites
were
9 x
10-6M.
have
sites
Scatchard equivalent
fragment
demonstrated
binding
analysis
and
No
high
that
on
had
The
role
molecule
of
binding
of
cross-link
thermal the
sites
fibrinogen
et that
binding
not
a-chain,
the
The
initial
a-chain
C-terminal are
stabilized
(4)
we
have
portion by
high
are
affinity
located
showed
constant
sites
in
that of
were
in
all
the
the
approximately
demonstrated
for
remnant (7). calcium
investigated
of
of
the
plasmin
on
in
fragments
Since
we
ions
against
whether
D1
the
product
Dl
The
has initial
reduced
concluded molecule
well
recently
occupation and
of
the
3 high
the
fibrin
that
the
involving
affinity
reaction
by addition
of
calcium the
velocity
of
calcium
ions
binding
C-terminal
part
of
(6).
Dl and D-dimer shown
further and
have
than
fibrinogen
slightly
have
been
fibrinogen
(4).
(5).
action
We
rather
that
calcium
Marguerie
the
denaturation.
digestion
has
protect
degradation
was
a zone
fibrinogen
to
ions
demonstrated
plasmin
site
(3)
of
shown
calcium
plasmin
(3).
located
acid
of
specific
with
been
fibrinogen
have
al.
by magnesium were
3
ION
polyrnerisation also
and
further
are
digestion
centres
(2) the
from
Mzrguerie
the has
presence
stabilizes
D-dimer
binding
in
Calcium
that site
product
but
calcium
against
the
a dissociation
affinity
the
E.
(1).
demonstrated
of
fibrinogen
INTRODUCT
documented
2
human
345
is devoid
both
proteolytic
D-dimer
sites.
that
have
of its
fragments digestion
specific
Dl
and
D-dirrer
with
plasmin
calcium
binding
3i6
MATERIALS Fibrinogen sulphate linked
fibrin
column
(4).
8.6
0.005
M Tris,
0.15
from
purification
from
Chelex
100
DE
(BioRad)
immediately glassware
the
prior that
7.4 with
samples
treatment
to the
had been washed
with
(Elgastat).water
(calcium
Chelex-treated
(5) before
Equilibrium Tris
HCI
buffer
Calcium to 4.7
dialysis
et al.
7.5
was added as CaCl2 Protein
x 10-4M.
constant
for
each
over
calcium
(0.1
diluted
ml)
were
10 minutes
removed,
on an LS
Further and for
233
aliquots
to confirm
the
out
by atomic
nitrous
oxide/acetylene
Radiochemical
Centre
calcium
taken
as described
for
lnstagel
protein
out
in
with
distilled
The
prepared
the
range 7-15
in 5 mM
Donnan
effects.
of 3.5
mg/ml
x 1(r6
but was
dialysis
buffer
24 hours
after
which
(Packard)
and counted
samples for
(Beckman). concentration
in the
determinations
presence
of SDS
Calcium
samples.
spectrometry
(Varian
45Ca
by
in duplicate
Chelex-treated
out
10 ml
flame.
out
prepared
10-7M).
to overcome
curve. carried
of the dialysed absorption
carried
rinsed
in the range
counter
for
added of Dl
the Sephadex
were
concentration
was
gel electrophoresis
integrity
carried
the
scintillation
were
polyacrylamide
was only
was carried
M NaCl
with
from
and thoroughly
0.5
was
was similarly of calcium
the same buffer.
solutions
out essentially
concentration Dialysis
Final
cm) in
use.
concentration
was used as a control.
(10) All
Dialysis
containing
elution
concentration
was carried
(5) but at 4OC. pH
calcium
EGTA
Dl
against
dialysis.
E.
x 2.5
52
buffer,
E was a by-product
After
dialysed
solutions
Marguerie
Trasylol.
Fragment
affinity
on a DE
to remove (100
in the presence
column.
and deionised were
units/ml
containing
to remove
of cross-
4B-lysine
10 mM phosphate
column
were
equilibrium
in
G200
had started.
52 cellulose
a Sepharose
gradient
plasmin
by ammonium digestion
chromatographed
2 Kallikrein
pH
digestion
by plasmin
dialysis,
M NaCl
digested
the protein
column,
after
on a Sephadex
M NaCi,
after
bank plasma
was passed through
(Bayer),
out
fibrinogen
minutes
aged blood
(9) and,
Trasylol
METHODS
was prepared
an 0 - 0.5
using
was carried
prepared a few
digest
plasmin
containing
purification
G200
The
colu*nn
from
D-dimer
(8).
to remove
cellulose pH
was prepared
fibrinogen
AND
CaCl2
(11)
(SDS-PAGE)
determinations
Techtron
AA5)
was obtained
were
using
from
a
the
(Amershom). RESULTS
Fragments criterion that
human,
These high
sites 3 sites
constant Marguerie
bovine
(5),
were
specific
for
were
was 8.7 et al.
Similar
and
E were
purified
fibrinogen calcium
of magnesium
to homogeneity
Calcium has 3 high
as calcium
ions
(Fig.
1).
by the
binding
studies
demonstrated
affinity
binding
sites
binding
was not affected
Scatchard
analysis
(Fig.
I).
by
showed
that
equiv lent, since a linear plot was achieved. The dissociation -8 x 10 M (Fig. 2) compared with 2 x 10-6M reported by at pH 7.5
studies
had one (fig.
binding
D-dimer
band on SDS-PAGE.
like
concentrations
these
Dl
Dl,
of a single
1).
was unaffected
showed These
(5). that high
D-dimer
had 2 highaffinity
affinity
by the presence
sites of
were
also
binding specific
10 mM magnesium
ions.
for
sites
and
calcium The
and
Scatchard
Vol.l3,No.3
plots for sites
cALCIb?l BISDIYG
(Fig. D-dimer were
2)
were
was
linear
9.5
demonstrated
x
and
1r6M on
parallel and
fragment
to
that E
for (Fig.
EC FIBRIXOGEN
The
fibrinogen. Dl
347
was
10.6
dissociation
x
ccnstant
1r6M.
No
binding
1).
FIG. Dependence
of
fibrinogen E on ions
calcium
(Fibg.),
the
present
in
the
weights and
Dl
180,000
and
90,000
Dialysis
was
were
(
and
calcium medium.
for
fibrinogen,
340,000, respectively.
0
10
to Dl
dialysing
carried
of of
of
used
D-dimer
absence
binding
D-dimer,
concentration
Molecular
presence
1
mM
out
in
the
) and
in
the
magnesium
ions
( 0 ).
FIG. Scatchord
analysis
dependence per free for
mole
of on
calcium fibrinogen
of
the ions.
Data
(upper), Dl
calcium
bound/mole ion
ions
bound
concentration
and
calcium
the
calcium
(middle) free
2
is
of shown
D-dimer
(lower).
r
protein concentration.
-
moles c
-
148
CALCIPI
BIh-DI?;CL FIBRIINOGEX
DISCUSSION The
high
exhibited
affinity
parallel
products
are derived
ccnformational obtained
6 seporate This
fibrinogen. of
; our work
constant
temperature
used by Marguer ie.
Dl
and O-dimer Our
(4).
to high
affinity
C terminus the hold
sites
of the
plasmin
fragment
on the
of the
The
abnormal
the
y chain
correction
products
concentration
may play
a more
prateolytic
thrombin time
important
degradation
role
since
activity
as inhibitors
biological
activity
correlates
After
digestion
of fragment
Readdition (IS). restoring its ability
of
Thus
in situ.
structure
in a strained
Plasmin D (7).
Of
molecule, the
C-terminal
wed
3 high
affinity
portion
found
3 binding
sites
on human
mojor fibrinogen
destroyed
by plasmin
solubility the
Marguerie
allows
binding
sites
Although
We
The
product have
rise
fragment
the
fragments the
to occur. of fragment
in the fibrinogen
we purified
isolated
D without
D may hold
do not
involve
fibrinogen
of the a-chain E,
(14).
attached
the digested reaction
little
monomer still
to 2 moles
remaining
from
Their
to fibrin
present
ionised
site
(13).
and therefore
fragment
partial
D have
is nevertheless
gelling
gives
fibrinogen.
treatment.
cross-link
digested
the
that
plosma
of the molecule
on fragment
in heterogeneity
degradotion
the
of fragment
though
(4). of
site
(16),
from we s_tilI
is not present
and may well
NDSK
fragment
on
be of
to determine whether the third calcium binding site involves the N of the 3 chains. This work has been unsuccessful to date due to problems with the isolated NDSK. If the remoining site does involve
C-terminal
towards
site
in the D domains
resulting
the other fibrinogen terminals
binding
that
calcium
to proceed
to note
to bind
even
of fibrinogen
located
the
of insteod
C terminus
D region
peptide
the partially
of the a-chains.
blood bank blood,
obility
monomer,
calcium
1 mole
2 of these are
in the
sites
the
that
conformation.
by increasing
products
their
stabilises
conformation
digestion the
the
insusceptible
protecting
cross-link
to fibrin
site
These
monomer polymerisation
with
the
calcium
to bind
are still
well
cross-link
It is interesting
merely
of fibrin
Dl
the (4).
of the
sites
involve
shown
has an elongation
the plasminolytic
biological
ions
by calcium of calcium
we have
y chain
binding than
sites
of the
time.
to room
is conferred
since
contain
can be achieved
The
(12).
as opposed
do not
digestion
I which
in the or the
These
in a plasmin
plasmin
Paris
has a prolonged
do not
difference
binding
by calcium
y chain
allows
fibrinogen
which
but differ
of temperature
digestion
products.
of
bovine
is due to direct
of cross-linking
stabilised
of the
calcium
plasmin
stability
degradation
themselves
of the thrombin
calcium
this
- the site
y chain
C terminus
Removal
that
as a result
one another
to a species
out at 4’C
Dl
constants
(5) for
and to the effect
to further
show
degradation
D have
the
stability
results
than
with
et al.
and
on the degradation
dissociation
in ogreement
was carried
sites
rather
The
can be attributed
D-dimer
the
molecule
by Marguerie
fibrinogen
dissociation
ions
are
reported
ions for
that
digestion.
experiments
difference
calcium
on fibrinogen,
suggests
the parent
plasmin
those
sites
This
from
during
of 4 from
binding
plots.
directly
change
from
by a factor affinity
calcium
Scatchard
portion
the same site.
of the a-chains,
This is not and Stuhrmann (17 ).
then
both a-chains
incompatible
The extended y chain digestion by plasmin extracellularly on account of the plasma calcium
with
the
must “bent
contribute banana”
is of course unable concentration.
model
to occur
of
Vol.13,Xo.3
CALCIUM
BIXDIKG
& FIBRINOGEX
349
REFERENCES 1.
DOOLITTLE,
2.
LY,
B.
effect 3.
4.
Adv. and
of
MARGEURIE,
PURVES,
L
.R.,
6.
to
MOSESSON,
. :
Humon
plasma J. 7.
11.
12.
B.
CHEVALLIER,
13.
14.
LOWRY,
O.H.,
15.
and
rabbit
172-181, and
of
: some 1977.
FRANKS,
:
J.J.
fibrinogen
and
:
M. Acta
UMFLEET, I.
fibrin
The
by
binding
490,
R.A.
Structural
94-l
and
and
catabolic
and
MCKEE,
03,
1977.
GALANAKIS,
related
studies
of
intermediates.
:
P.A.
A
re-examination
plasmin.
J.
Biol.
Purification
of
human
and
to
sarcoplosmic
by
BUTOW,
with
:
M. 415-443,
Chem.
250,
Calcium
binding
Biochemistry N.J.,
the
Fol in
bovine
1956.
:
R.A.
muscle.
ROSEBROUGH,
FARR,
Phenol
10,
the
2733-2737,
A.L.
1971.
and RANDALL,
reagent.
J.
Biol.
R.J.
Chem.
:
193,
1951.
:
D.
Abnormal
525-535,
structure
and
biological
PURVES,
L.R.
DRAY-ATTALI,
L.
and
interactions
LINDSEY,
.,
fibrin
10,
skeletal
29,
cross-link
L.J.
BLOMBACK, Kemi.
n measurement
MENACHE
and
protective
1972.
FRETTO,
and
J. of
(Stuttog)
fibrinogen
. Biophys.
solubility
fibrinogenland
Arkiv.
reticulum
261-275,
high
the
1975.
BLOMBACK,
Protei
are
to 494,
SUSCILLON,
J.S
5210-5219,
of
and
fibrin
1978.
Biochim
heterogeneities.
which
E.W.,
fibrinogen.
10.
G.
FINLAYSON,
cleavage
7210-7218,
474-484,
12,
fibrinogen,
G.
Res.
M.W.,
247,
Acta BROWN,
CHAGNIEL,
fibrinogens
the
calcium
products
fibrinogen.
Biol.Chem.
of
to
1973.
1973.
digestion
bovine
fibrinogen
FERGUSON, of
8.
Thrombosis
fibrinogen
of
204-209,
G.G.,
plasmin
G.,
calcium
binding
LINDSEY, the
the
l-109,
1,
Biochim.Biophys.
ions.
MARGUERIE,
D
The
of
27,
Denaturation
:
H.C.
:
G.
of
aspects Chem.
Haemostasis
feotures.
of
Prot.
GODAL,
structural
calcium
in
calcium.
Stobilisation
5.
Structural
:
R.F.
conversion.
G. G., peptide
of
fibrinogens.
Thrombos.
Diathes
hoemorrh
1973.
and
LARRIEU,
M. J.
activity.
LINDSEY,
BROWN, fibrin.
:
G.G.
fibrinogen.
of
:
Fragments
Thrombosis
S. G.
Afr.
and
Thrombosis
A
Res. role
J.
PURVES, Res.
for
Sci.
D 10,
L.R.
Correlation
calcium (In
12,
-
575-578, in
between
1977. the
structure
press).
:
Isolation
467-471,
1978.
of
the
350
16.
CALCIKY
SEMERARO,
N .,
the A a chain Thrombosis 17.
MARGUERIE, scattering
COLLEN,
heterogeneity
and Haemostasis. G. study
and
BIXDING
D.
and VERSTRAETE,
of human Paris.
STUHRMANN,
of bovine
fibrinogen.
~01.13,?r;o.3
r, FIBRIJOGEX
M.
fibrinogen.
:
Proc.
On 5th
the origin lnt.Cong.
of an
1975. H .B.
:
J.
MaL
A neutron Biol.
102,
small-angle 143-156,
1976.